Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Alector (ALEC)

Alector Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALEC
DateTimeSourceHeadlineSymbolCompany
05/03/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
05/03/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
05/03/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
05/03/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
02/03/202400:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALECAlector Inc
02/03/202400:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALECAlector Inc
02/03/202400:49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALECAlector Inc
02/03/202400:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALECAlector Inc
28/02/202412:00GlobeNewswire Inc.Alector to Participate in Upcoming Healthcare ConferencesNASDAQ:ALECAlector Inc
27/02/202421:41Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALECAlector Inc
27/02/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALECAlector Inc
27/02/202421:05GlobeNewswire Inc.Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ALECAlector Inc
20/02/202421:05GlobeNewswire Inc.Alector to Host Fourth Quarter and Full-Year 2023 Earnings CallNASDAQ:ALECAlector Inc
08/02/202423:59Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALECAlector Inc
08/02/202412:00GlobeNewswire Inc.Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s DiseaseNASDAQ:ALECAlector Inc
07/02/202412:00GlobeNewswire Inc.FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)NASDAQ:ALECAlector Inc
19/01/202414:20GlobeNewswire Inc.Alector Announces Closing of Public OfferingNASDAQ:ALECAlector Inc
19/01/202411:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALECAlector Inc
19/01/202411:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ALECAlector Inc
17/01/202413:54GlobeNewswire Inc.Alector Announces Pricing of Public Offering of Common StockNASDAQ:ALECAlector Inc
16/01/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALECAlector Inc
16/01/202421:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ALECAlector Inc
16/01/202421:01GlobeNewswire Inc.Alector Announces Proposed Public Offering of Common StockNASDAQ:ALECAlector Inc
06/12/202323:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
06/12/202323:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
06/12/202323:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
06/12/202323:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
06/12/202323:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
02/12/202301:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALECAlector Inc
02/12/202301:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALECAlector Inc
 Showing the most relevant articles for your search:NASDAQ:ALEC